IP Library Granted Patent US 9,861,589
Granted Patent B2
US 9,861,589 · App. 15/198,271 · Granted Jan 9, 2018

Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,589
App. No.
15/198,271
Granted
Jan 9, 2018
Kind
B2
Abstract

The instant invention provides for novel cationic lipids of Formula A that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids with one short lipid chain coupled with inclusion of hydrolysable functionality in the lipid chains to enhance the efficiency and tolerability of in vivo delivery of siRNA.

Claims (28)

1. A compound of formula A:

Wherein:

R 1 is H or a hydroxyl protecting group;

R 2 is H, OR 3 ; and

R 3 is an alkenyl.

2. The compound of claim 1 , wherein the hydroxyl protecting group is tert-butyldiphenylsilyl (TBDPS).

3. The compound of claim 1 , wherein R 2 is H or —OCH 2 CH═CH(CH 2 ) 5 CH 3 .

4. The compound of claim 1 , wherein the compound is of structure:

5. The compound of claim 1 , wherein the compound is of structure:

6. A method for preparing a carboxylic acid of structure:

wherein R 1 is a hydroxyl protecting group, the method comprising oxidizing an aldehyde of structure:

7. The method of claim 6 , wherein said oxidizing is with Oxane.

8. The method of claim 6 , wherein R 1 is TBDPS.

9. A method for preparing an ester of structure:

wherein R 1 is a hydroxyl protecting group and R 3 is an alkenyl, the method comprising reacting a carboxylic acid of structure:

with an alkenyl alcohol.

10. The method of claim 9 , wherein the alkenyl alcohol is a C9-alcohol.

11. The method of claim 9 , wherein the alkenyl alcohol is HOCH 2 CH═CH(CH 2 ) 5 CH 3 .

12. The method of claim 9 , wherein R 1 is TBDPS.

13. The method of claim 9 , wherein R 3 is —CH 2 CH═CH(CH 2 ) 5 CH 3 .

14. The method of claim 9 , further comprising a step of oxidizing an aldehyde of structure:

to form the carboxylic acid of structure:

15. The method of claim 14 , further comprising a step of oxidizing a diol of structure:

to form the aldehyde of structure:

16. A compound of structure:

wherein:

R 1 is a hydroxyl protecting group.

17. The compound of claim 16 , wherein the compound is of structure:

Assignments (3)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2017
From: COLLETTI, STEVEN L.; STANTON, MATTHEW G.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 043612/0102 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2017
From: MERCK SHARP & DOHME CORP.
To: SIRNA THERAPEUTICS, INC.
Reel/Frame 043612/0109 →